Add BrightSurf on Google Email

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

A new study published in The New England Journal of Medicine and the European Heart Journal finds that beta blockers, commonly prescribed after a heart attack, provide no clinical benefit for patients with preserved heart function. Women treated with beta blockers had a higher risk of death, heart attack, or hospitalization for heart f...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2025

Chung-Ang University researchers reveal strange dynamics of nanoparticle growth and shrink

Researchers developed a new model and theory to explain nanoparticle growth dynamics, accounting for six essential characteristics of nanoparticle growth. The new theory provides fresh physical insights into the role of nanoparticle motion and configurational degeneracy on their nucleation and growth.

SourceChung Ang University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 28, 2025

How AI could speed the development of RNA vaccines and other RNA therapies

Researchers used machine-learning models to design nanoparticles that can deliver RNA to cells more efficiently. The approach accelerated the identification of optimal ingredient mixtures in lipid nanoparticles, leading to better delivery vehicles for RNA vaccines and mRNA therapies. This could dramatically speed up the development of ...

SourceMassachusetts Institute of Technology·JournalNature Nanotechnology·DateAug 15, 2025

Challenging popular “ancient psychedelic mysteries” theory

Researchers Dr. Sharday Mosurinjohn and Dr. Richard Ascough critique the 'psychedelic mysteries hypothesis' in a new article, arguing that it relies on circumstantial evidence rather than solid historical scholarship. They advocate for responsible curiosity and a focus on living traditions to unlock psychedelic wisdom.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPsychedelic Medicine·TypeCommentary/editorial·DateAug 5, 2025

New technology developed by the University of Bath is a step towards swapping injections for pills

Researchers at University of Bath have developed a system that can transport therapeutic proteins across the gut wall and into the bloodstream, enabling medication delivery via pill. The new technology has shown consistent delivery rates, with potential to transform lives of patients who currently inject themselves daily.

SourceUniversity of Bath·JournalJournal of Controlled Release·TypeExperimental study·DateAug 4, 2025

Shaping the future of mRNA based drug delivery

Researchers discovered that subtle differences in molecular structure can significantly affect mRNA-based drug performance. The study found that optimizing stereoisomers of ionizable lipids like ALC-315 could lead to safer vaccines, as the (S,S)-form delivers mRNA efficiently with reduced toxicity.

SourceHokkaido University·JournalJournal of the American Chemical Society·TypeExperimental study·DateAug 1, 2025

Characterizing antibodies targeting antisense oligonucleotide modifications

Researchers validated panels of antibodies targeting clinically relevant nucleic acid modifications to visualize antisense oligonucleotides in both in vitro and in vivo studies. The tools enable detection of modified nucleic acids irrespective of sequence, facilitating multiple clinical and pre-clinical workflows.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalNucleic Acid Therapeutics·TypeExperimental study·DateJul 31, 2025

Pusan National University researchers unveil game-changing UV-fueled shape-shifting and shape-fixing smart materials

Researchers at Pusan National University have created novel materials called disulfide-based covalent adaptable networks (DS-CAN) that can change, fix, and retain their shape reversibly using magnetic fields and ultraviolet light. These materials enable UV- or heat-assisted shape fixation after deformation, which is also reversible.

SourcePusan National University·JournalAdvanced Materials·TypeExperimental study·DateJul 14, 2025

Exciting progress in ferroptosis-based nanomedicine for bladder cancer

Researchers develop self-assembling nanoparticles that induce ferroptosis in bladder cancer cells while reprogramming the tumor immune microenvironment, boosting anti-tumor activity. The nanomedicine has dual functions as a multifaceted approach to overcome treatment resistance and is Clinically translatable.

SourceResearch·JournalResearch·TypeExperimental study·DateJul 6, 2025

Pusan National University study reveals engineered bacterial vesicles to combat antimicrobial resistance

Researchers from Pusan National University have developed engineered bacterial vesicles that use a novel surface-displaying protein to selectively target and eliminate E. coli and S. aureus bacteria. These vesicles, derived from lactic acid bacteria, offer a promising alternative to conventional antibiotics.

SourcePusan National University·JournalChemical Engineering Journal·TypeExperimental study·DateJul 2, 2025

New gene therapy delivery device could let hospitals create personalized nanomedicines on-demand

A new gene therapy delivery device called NANOSPRESSO could revolutionize how hospitals treat rare diseases by allowing them to create personalized nanomedicines in-house. This democratized approach to precision medicine could boost access to low-cost bespoke gene and RNA therapies, especially in low-resource settings.

SourceFrontiers·JournalFrontiers in Science·TypeSystematic review·DateJun 26, 2025

Wyss Institute at Harvard University announces appointment of Natalie Artzi, Ph.D., to Associate Institute Director

Dr. Natalie Artzi joins the Wyss Institute as Associate Institute Director, working closely with Don Ingber to shape strategic direction and advance research and translation efforts. She leads a world-class research program focused on developing tissue- and cell-responsive nanostructures for disease tracking and treatment.

Experimental Drug Development Centre granted US FDA fast track designation for antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma

The Experimental Drug Development Centre's EBC-129, an antibody-drug conjugate targeting pancreatic cancer, has received FDA fast track designation. The treatment is undergoing Phase 1 clinical trials and aims to provide new treatment options for patients with solid tumours.

Decision involvement and trust shape seniors’ willingness to cut back prescriptions

A qualitative study found that patients' attitudes towards deprescribing are shaped by their perception of medication's benefits and risks, as well as their level of autonomy. Patients who valued negative aspects of medication and had a proactive approach to health were more likely to consider cutting back on prescriptions.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMay 27, 2025

Cannabis use disorder is increasing rapidly, especially among older adults and people living with HIV

A new study finds that cannabis use disorder diagnoses rose substantially across all age groups, race/ethnicity, and comorbidity subgroups nationwide from 2000 to 2022. People living with HIV experienced the greatest relative increase in CUD diagnoses, particularly among older adults.

SourceBoston University School of Public Health·JournalJournal of Addiction Medicine·TypeObservational study·DateMay 21, 2025

Self-assembly of a large metal-peptide capsid nanostructure through geometric control

Researchers successfully constructed a large molecular spherical shell structure with the geometric topology of a regular dodecahedron through entanglement of peptides with metal ions. The resulting M60L60 metal-peptide shell exhibits remarkable stability against heat, dilution, and oxidative conditions, making it a promising platform ...

SourceInstitute of Science Tokyo·JournalChem·TypeComputational simulation/modeling·DateMay 9, 2025

New technology facilitates delivery of advanced medicines

Researchers at Karolinska Institutet have developed a technique to deliver gene editors and protein therapeutics to cells using engineered extracellular vesicles. The method shows promising results in animal studies, highlighting the potential for treating genetic diseases and neurological disorders.

SourceKarolinska Institutet·JournalNature Communications·TypeExperimental study·DateApr 30, 2025

Scientists from IOCB Prague are on track of finding a treatment for autoimmune hair loss

Researchers from IOCB Prague have developed a compound that could treat alopecia areata by targeting the immune system. The substance, a series of prodrugs based on derivatives of itaconic acid, has shown efficacy in mice tests and may be administered orally.

Multidisciplinary workshops enhance respectful communication among community pharmacists

A study of 961 Japanese community pharmacists found that regular attendance at local multidisciplinary workshops was positively correlated with assertive communication styles. This suggests that such workshops may play a crucial role in promoting respectful communication among healthcare professionals, leading to better patient outcomes.

SourceUniversity of Tsukuba·JournalJournal of Pharmaceutical Health Care and Sciences·DateJan 29, 2025

NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

The team's novel technique enables high-throughput screening of nanoparticle shapes, sizes, and modifications, reducing associated screening costs. The research demonstrates the distinct preferences of tumour cells for certain nanoparticle configurations, enabling personalized cancer treatments that are safer and more effective.

SourceNational University of Singapore·JournalAdvanced Functional Materials·TypeExperimental study·DateJan 27, 2025

New lignin-based hydrogel breakthrough for wound healing and controlled drug release

The study presents a lignin-based hydrogel that combines mechanical strength with bioactivity, promoting wound healing and sustained drug release. The hydrogel's controlled-release properties make it an ideal candidate for treating complex wounds and reducing medication side effects.

SourceJournal of Bioresources and Bioproducts·JournalJournal of Bioresources and Bioproducts·TypeExperimental study·DateNov 12, 2024

Differences in Drug Shortages in the US and Canada

A study published in JAMA found that drug-related reports of supply chain issues were 40% less likely to result in meaningful drug shortages in Canada compared to the US. This highlights the importance of global cooperation to curb the effects of drug shortages and strengthen pharmaceutical supply chains.

SourceJAMA Network·JournalJAMA·DateOct 31, 2024

Speedier and more effective treatment of serious illnesses thanks to scientists from IOCB Prague

Researchers from IOCB Prague have created new-generation prodrug activators that can enhance the effectiveness of anti-cancer therapies by targeting malignant tumours more precisely. These compounds allow for faster release of drugs in the body, increasing the utilization of administered doses.

SourceInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)·JournalAngewandte Chemie International Edition·TypeExperimental study·DateOct 15, 2024